summary_short: "This bill requires reporting on pharmaceutical rebates to improve transparency in prescription drug costs."
summary: |
  This bill, SB1213, changes the way payments and discounts from drug manufacturers are reported in Missouri. It requires pharmacy benefits managers that work with the state's health plan to file annual reports on the total rebates they collect from drug companies. These reports will help the state understand how much money is saved through rebates and ensure transparency in drug pricing. The bill affects pharmacies, drug manufacturers, health plans, and government officials involved in overseeing healthcare costs and drug pricing transparency.
tags:
  - Healthcare
  - Prescription Drugs
  - Transparency
  - Rebate Reporting
  - Missouri
  - Public Policy
